Prime Medicine said Friday it successfully used a new, ultra-versatile form of genetic surgery called prime editing to edit liver cells in monkeys.
The results, presented at the European Society of Gene & Cell Therapy meeting in Brussels, are a major step for a technology that could transform treatment of numerous diseases.
advertisement
“I think the big celebration here is we’re showing, in primates, for the company, that we have a delivery system that is working and is safe,” said Jeremy Duffield, Prime’s chief scientific officer.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Bird flu surveillance in wastewater gets boost from consortium
Next article： Supreme Court strikes down use of affirmative action
Next article： Supreme Court strikes down use of affirmative action
.png?upscale=true&width=1212&upscale=true&name=vTFET-vaccine-makers-surge-on-bird-flu-fears(3).png)
